Mapi Pharma to Host a Key Opinion Leader Webinar on
GA Depot is a Potential Long Acting Injection Solution for Multiple Sclerosis Patients Positive Results from Phase III GA Depot Study in Relapsing MS to...
Source: globenewswire.com
📰 Multiple Sclerosis Care News
Multiple Sclerosis Care News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Multiple Sclerosis Care. Real-time updates on events, politics, business and more.
B-Cell Repletion Common With MS Drug, but No Symptom Worsening
Although some repletion of B cells occurs with the B-cell depleting MS drug ocrelizumab, the effect does not appear to be associated with symptom worsening or a wearing off effect.
United States Scottd Newsome Joshuad Katz Johns Hopkins University Neurosciences Consultation Consortium Of Multiple Sclerosis Centers Elliot Lewis Center
Source: medscape.com